Home LiteratureArticle Details
PMID: 3466181 Published · ppublish English Journal Article

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M

Abstract

The S gene encoding the major surface polypeptide of hepatitis B virus is preceded by the region pre-S(2) with a capacity to code for 55 amino acid residues. In the product of region pre-S(2), the sequence of 19 amino acid residues (amino acids 14-32 from the N terminus) representing an area of high local hydrophilicity is shared by viral strains of subtypes adr, ayw, and ayr; residue 22, phenylalanine, is replaced by leucine in a strain of the other subtype, adw. A synthetic peptide vaccine involving these 19 amino acid residues, when given to two chimpanzees, raised antibodies that bound to viral particles and protected the animals from challenge with 10(6) chimpanzee infectious doses of hepatitis B virus.

MeSH Terms
Animals Antigens/immunology Genes, Viral Hepatitis B/prevention & control Hepatitis B Surface Antigens/immunology Hepatitis B virus/classification,genetics,immunology Oligopeptides/immunology Pan troglodytes Species Specificity Vaccines, Synthetic/immunology Viral Proteins/immunology Viral Vaccines/immunology
Chemicals
Antigens Hepatitis B Surface Antigens Oligopeptides Vaccines, Synthetic Viral Proteins Viral Vaccines
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Itoh Y
Takai E
Ohnuma H
Kitajima K
Tsuda F
Machida A
Mishiro S
Nakamura T
Miyakawa Y
Mayumi M
References (44)
44 references, click to expand
  1. Solid-phase peptide synthesis.
    Adv Enzymol Relat Areas Mol Biol. 1969;32:221-96 PMID: 4307033
  2. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.
    Proc Natl Acad Sci U S A. 1982 Jul;79(14):4400-4 PMID: 6181506
  3. Detection of additional antigenic determinants of hepatitis B antigen.
    J Immunol. 1972 Oct;109(4):842-8 PMID: 4116360
  4. Large-scale isolation of Dane particles from plasma containing hepatitis B antigen and deomnstration of circular double-stranded DNA molecule extruding directly from their cores.
    J Immunol. 1976 Oct;117(4):1392-7 PMID: 977955
  5. Hepatitis B e antigen and infectivity of hepatitis B virus.
    J Infect Dis. 1977 Oct;136(4):571-6 PMID: 908854
  6. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.
    Prog Med Virol. 1978;24:40-69 PMID: 212785
  7. A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.
    Gastroenterology. 1979 Feb;76(2):242-7 PMID: 103774
  8. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates.
    Biochemistry. 1979 Feb 20;18(4):690-3 PMID: 84683
  9. A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles.
    J Immunol. 1980 Apr;124(4):1589-93 PMID: 6154075
  10. Demonstration of albumin receptors on isolated human hepatocytes by light and scanning electron microscopy.
    Hepatology. 1982 Nov-Dec;2(6):832-5 PMID: 6292068
  11. A glycopeptide containing 15 amino acid residues derived from hepatitis B surface antigen particles: demonstration of immunogenicity to raise anti-HBs in mice.
    Mol Immunol. 1982 Sep;19(9):1087-93 PMID: 7144754
  12. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.
    Nucleic Acids Res. 1983 Mar 25;11(6):1747-57 PMID: 6300776
  13. Structural relationships between minor and major proteins of hepatitis B surface antigen.
    J Virol. 1983 May;46(2):626-8 PMID: 6842680
  14. A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins.
    Gastroenterology. 1983 Aug;85(2):268-74 PMID: 6305755
  15. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.
    Nature. 1983 Aug 25-31;304(5928):699-703 PMID: 6310403
  16. Albumin binding sites of human hepatocytes.
    Liver. 1983 Oct;3(5):290-4 PMID: 6316067
  17. Human hepatitis B vaccine from recombinant yeast.
    Nature. 1984 Jan 12-18;307(5947):178-80 PMID: 6318124
  18. A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins.
    Gastroenterology. 1984 May;86(5 Pt 1):910-8 PMID: 6323244
  19. Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus.
    Science. 1984 Apr 27;224(4647):392-5 PMID: 6200931
  20. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA.
    JAMA. 1984 Jun 1;251(21):2812-5 PMID: 6232402
  21. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection.
    Gastroenterology. 1984 Jul;87(1):159-64 PMID: 6724259
  22. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
    N Engl J Med. 1984 Aug 23;311(8):496-501 PMID: 6235453
  23. Seroconversion rates with hepatitis B vaccine.
    Ann Intern Med. 1984 Oct;101(4):564 PMID: 6236728
  24. Large surface proteins of hepatitis B virus containing the pre-s sequence.
    J Virol. 1984 Nov;52(2):396-402 PMID: 6492255
  25. Clinical evaluation of a recombinant hepatitis B vaccine.
    Lancet. 1984 Nov 24;2(8413):1174-5 PMID: 6150233
  26. Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens.
    J Immunol. 1985 Feb;134(2):1212-6 PMID: 2981263
  27. Immunogenicity of recombinant yeast hepatitis B vaccine.
    Lancet. 1985 Jan 12;1(8420):108-9 PMID: 2857007
  28. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
    Arch Intern Med. 1985 Feb;145(2):305-9 PMID: 3977491
  29. Hepatitis B virus contains pre-S gene-encoded domains.
    Nature. 1985 May 9-15;315(6015):154-6 PMID: 2581144
  30. Low immune responses to hepatitis B vaccination among healthy subjects.
    Lancet. 1985 May 18;1(8438):1152 PMID: 2860350
  31. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.
    Science. 1985 Jun 7;228(4704):1195-9 PMID: 2408336
  32. Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame.
    J Virol. 1985 Jul;55(1):223-31 PMID: 2409297
  33. Polypeptides coded for by the region pre-S and gene S of hepatitis B virus DNA with the receptor for polymerized human serum albumin: expression on hepatitis B particles produced in the HBeAg or anti-HBe phase of hepatitis B virus infection.
    J Immunol. 1986 May 1;136(9):3467-72 PMID: 3007621
  34. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
    N Engl J Med. 1980 Oct 9;303(15):833-41 PMID: 6997738
  35. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.
    Nature. 1979 Oct 25;281(5733):646-50 PMID: 399327
  36. Biology of hepatitis B virus.
    Science. 1981 Jul 24;213(4506):406-11 PMID: 6264599
  37. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.
    Proc Natl Acad Sci U S A. 1981 Jun;78(6):3403-7 PMID: 6167985
  38. Prediction of protein antigenic determinants from amino acid sequences.
    Proc Natl Acad Sci U S A. 1981 Jun;78(6):3824-8 PMID: 6167991
  39. Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides.
    Nature. 1982 Jan 14;295(5845):158-60 PMID: 6173758
  40. Anti-influenza response achieved by immunization with a synthetic conjugate.
    Proc Natl Acad Sci U S A. 1982 Jan;79(2):569-73 PMID: 6176996
  41. Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.
    Proc Natl Acad Sci U S A. 1982 Jan;79(2):579-82 PMID: 6176997
  42. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.
    Nature. 1982 Jul 1;298(5869):30-3 PMID: 7045684
  43. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast.
    Nature. 1982 Jul 22;298(5872):347-50 PMID: 7045698
  44. The heterogeneity of Australia antigen.
    J Infect Dis. 1971 Jun;123(6):671-5 PMID: 4106744
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1986-12-00
Pages
9174-8
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC387097
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]